Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer

por Kerner, Gerald SMA, van Dullemen, Leon FA, Wiegman, Erwin M, Widder, Joachim, Blokzijl, Edwin, Driever, Ellen M, van Putten, John WG, Liesker, Jeroen JW, Renkema, Tineke EJ, Pieterman, Remge M, Mertens, Marc JF, Hiltermann, Thijo JN, Groen, Harry JM
Publicado 2014

Common and Rare EGFR and KRAS Mutations in a Dutch Non-Small-Cell Lung Cancer Population and Their Clinical Outcome

por Kerner, Gerald S. M. A., Schuuring, Ed, Sietsma, Johanna, Hiltermann, Thijo J. N., Pieterman, Remge M., de Leede, Gerard P. J., van Putten, John W. G., Liesker, Jeroen, Renkema, Tineke E. J., van Hengel, Peter, Platteel, Inge, Timens, Wim, Groen, Harry J. M.
Publicado 2013

Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study

por Groen, Harry J. M., van der Heijden, Erik H. F. M., Klinkenberg, Theo J., Biesma, Bonne, Aerts, Joachim, Verhagen, Ad, Kloosterziel, Corinne, Pieterman, Remge, van den Borne, Ben, Smit, Hans J. M., Hoekstra, Otto, Schramel, Frans M. N. H., van der Noort, Vincent, van Tinteren, Harm, Smit, Egbert F., Dingemans, Anne-Marie C.
Publicado 2019